LTRN
Lantern Pharma Inc. · Healthcare
10% owner Aaron G.l. Fletcher sold $500K of Lantern Pharma Inc.
Sold$499,997
$3.44Price
145,348Shares
−9%Stake
What LTRN did after the filing
- The stock from Fri, Dec 1 open, $3.97
- −6.0%
- S&P 500, same days
- +4.0%
Measured over 30 trading days, to the Jan 17 close.
Traded Wed, Nov 29. Filed Fri, Dec 1, 1:01 AM ET, before the open. Returns use the Dec 1 open and the Jan 17 close. Not investment advice.